November 2020.
Daniel A. Vorobiof, MD, chief medical director of Belong.Life, discusses financial toxicity in oncology.
Financial toxicity is an ongoing problem in the oncology space that has not been properly addressed to date, Vorobiof says.
In the United States, cancer is among the most expensive diseases to treat, along with heart disease, Vorobiof says. Moreover, financial toxicity is a global problem and cancer-related treatment expenses are continuing to rise.
Although financial toxicity may affect all patients differently, some health care professionals have been detached from the widespread burden financial toxicity can place on a patient with cancer, concludes Vorobiof.
